MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problems
Mechanical Problem (1384); Use of Device Problem (1670); Material Integrity Problem (2978); Protective Measures Problem (3015)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/05/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Continuation of d10: product id: 203cx product type: cables and accessories.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that during a cryo ablation procedure, an unknown system notice was received while the balloon catheter was being manipulated indicating that there was blood in the balloon catheter.Blood was visible in the connection between the balloon catheter and coaxial umbilical cable.It was also reported that the balloon catheter ruptured and that it was difficult to occlude the pulmonary veins.The balloon catheter and coaxial umbilical cable were subsequently replaced. the case was completed with cryo. no patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Product event summary: the data files and the afapro28 balloon catheter with lot number 25323 were returned and analyzed.No patient data file was received.The received failure data file contained failure records for the date of the event.The failure data file showed persistent system notice 50006 (the safety system has detected blood in the catheter handle stopped the injection and disabled the vacuum) on the reported date of the event.External visual inspection of the balloon segment showed blood/fluid inside the balloon.The catheter smart chip data was reviewed.The data indicated the catheter was used for three applications.However, the catheter usage date recorded on the smart chip 2023-09-05 did not correspond to the event date.During functional testing, the console terminated the application and triggered system notice 50005 (the safety system detected fluid in the catheter and stopped the injection).Pressurizing of the outer balloon identified the outer balloon proximal bond was leaking and detached from the shaft.In conclusion, the the reported visible blood issue was confirmed and the returned balloon catheter failed the returned product inspection due to a bond detachment at the outer balloon proximal bond.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|